Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.405SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.296SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.412SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
AC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.1.421SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.364SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.82SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.61SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.47SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.251SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.2.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CA.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BN.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BE.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BL.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BS.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.7.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CP.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JU.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CJ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BM.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
DE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
BF.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
BF.7.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.75.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BF.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.51SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CA.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
AY.132 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.4.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
KF.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CS.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.83SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used